The Sterlin-2 liquid nitrogen plant was installed in mid-September and started producing liquid nitrogen in early October. The LN2 plant is currently producing liquid nitrogen at a rate of 15 litres per hour. The 2000 litre liquid nitrogen holding vessel is automatically filled with liquid nitrogen once its level drops to 80%.
Postdoctoral Research Fellow Jennifer Maroa, K-RITH/MPS Investigator ThumbiNdung’u and Research Associate Emily Wong attended and each presented a talk at the Federation of African Immunological Societies Conference in Nairobi, Kenya from the 30 November to the 4 December.
K-RITH hosted its fourth Interactive Biostatistics Course in November this year. Lori Chibnik, PhD, MPH, a Biostatistician at Harvard University, facilitated the course, where students work with data from their own projects to understand basic statistical concepts and methods used in medical research.
The November K-RITH seminar series had the privilege of having Professor Stewart Cole from the Global Health Institute, Lausanne, Switzerland, speaking about conventional and unconventional approaches to Tuberculosis drug discovery.
Director of the Ragon Institute of MGH, MIT and Harvard, Bruce Walker, will be conducting a seminar with five guest speakers, who will be focusing on novel technologies for understanding the human immune response and in vaccine development.
Head of the University of the Witwatersrand node of the DST/NRF Centre of Excellence for Biomedical TB Research, Professor Bavesh Kana (PhD), will be hosting the next K-RITH Seminar Series. This Seminar Series will focus on the remodeling of mycobacterialpeptidoglycan during growth and tuberculosis disease.
Associate Professor, Muazzam Jacobs, will speak on 'Tumour Necrosis Factor Receptor (TNF-TNFR) interaction - a critical requirement for host immune protection against Mycobacterium tuberculosis infection' for the September K-RITH Seminar Series.
Professor Lynn Morris, Chief Specialist Scientist and head of the HIV Virology laboratories within the Centre of HIV & STI’s at NICD will be speaking on 'Prospects for an antibody-based HIV vaccine' at the August K-RITH Seminar.